Literature DB >> 16740193

Socioeconomic correlates of antibody levels to enteric pathogens among Israeli adolescents.

T Hasin1, R Dagan, G Boutboul, E Derazne, O Atias, D Cohen.   

Abstract

We examined the association between socioeconomic status and the level of serum antibodies to selected faeco-orally transmitted pathogens among Israeli adolescents. Random samples of eighty volunteers aged 12-15 years from high (HSL), medium (MSL) and low (LSL) standard of living towns were included in the study. Serum samples were examined by radioimmunoassay for HAV and by in-house-developed ELISA systems for IgA and IgG antibody levels against Shigella sonnei, S. flexneri, E. coli O157:H7 lipopolysacchride and Cryptosporidium parvum antigens. Seropositivity to HAV was highest (98.8%) in the LSL towns and lowest (25%) in the HSL towns, showing a statistically significant linear trend. Antibody levels to the other enteropathogens had gender variation, with higher titres in females. Significantly lower titres in the HSL towns were found for: IgA anti-S. sonnei in females (P<0.001); IgG anti-S. sonnei in females (P=0.024) and males (P=0.033); IgG anti-S. flexneri in females (P=0.016). Inverse linear association with socioeconomic status was found for IgA anti-C. parvum in females (P<0.001); IgA anti-E. coli O157:H7 in females (P<0.001) and males (P=0.024). A statistically significant association between HAV seropositivity and higher titres of IgA anti-S. sonnei and E. coli O157:H7 was shown. In conclusion, exposure to enteropathogens transmitted via the faecal-oral route in communities of lower socioeconomic status is reflected in a higher prevalence of lifelong lasting antibodies to HAV, and higher levels of antibodies to bacterial and protozoan enteropathogens. Among females, the levels of specific serum antibodies are higher and more strongly associated with low socioeconomic status.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16740193      PMCID: PMC2870538          DOI: 10.1017/S0950268806006455

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  27 in total

1.  Cryptosporidium infection in Bedouin infants assessed by prospective evaluation of anticryptosporidial antibodies and stool examination.

Authors:  G Robin; D Fraser; N Orr; T Sela; R Slepon; R Ambar; R Dagan; S Le Blancq; R J Deckelbaum; D Cohen
Journal:  Am J Epidemiol       Date:  2001-01-15       Impact factor: 4.897

2.  Gender differences in the reactogenicity of measles-mumps-rubella vaccine.

Authors:  T Shohat; M S Green; O Nakar; A Ballin; P Duvdevani; A Cohen; M Shohat
Journal:  Isr Med Assoc J       Date:  2000-03       Impact factor: 0.892

3.  Prospective cohort studies of shigellosis during military field training.

Authors:  D Cohen; T Sela; R Slepon; M Yavzori; R Ambar; N Orr; G Robin; O Shpielberg; A Eldad; M Green
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2001-02       Impact factor: 3.267

4.  Immune response to non-O157 Vero toxin-producing Escherichia coli in patients with hemolytic uremic syndrome.

Authors:  K Ludwig; M Bitzan; S Zimmermann; M Kloth; H Ruder; D E Müller-Wiefel
Journal:  J Infect Dis       Date:  1996-11       Impact factor: 5.226

5.  The prevalence of antibodies to hepatitis A virus and its determinants in The Netherlands: a population-based survey.

Authors:  F Termorshuizen; J W Dorigo-Zetsma; H E de Melker; S van den Hof; M A Conyn-Van Spaendonck
Journal:  Epidemiol Infect       Date:  2000-06       Impact factor: 2.451

6.  Natural history of Giardia lamblia and Cryptosporidium infections in a cohort of Israeli Bedouin infants: a study of a population in transition.

Authors:  D Fraser; R Dagan; L Naggan; V Greene; J El-On; Y Abu-Rbiah; R J Deckelbaum
Journal:  Am J Trop Med Hyg       Date:  1997-11       Impact factor: 2.345

7.  Intra-familial and extra-familial risk factors associated with Cryptosporidium parvum infection among children hospitalized for diarrhea in Goiânia, Goiás, Brazil.

Authors:  Maria Das Graças Cabral Pereira; Edward Robert Atwill; Alverne Passos Barbosa; Simonne Almeida E Silva; Marco Tulio Antonio García-Zapata
Journal:  Am J Trop Med Hyg       Date:  2002-06       Impact factor: 2.345

8.  Shigella bacteremia: a retrospective study.

Authors:  David Greenberg; Shai Marcu; Rimma Melamed; Matityahu Lifshitz
Journal:  Clin Pediatr (Phila)       Date:  2003-06       Impact factor: 1.168

9.  Epidemiological, clinical and microbiological features of shigellosis among hospitalized children in northern Israel.

Authors:  O Admoni; P Yagupsky; A Golan; Y Kenes; G Schifroni; I Horowitz
Journal:  Scand J Infect Dis       Date:  1995

10.  Sex differences in the humoral antibody response to live measles vaccine in young adults.

Authors:  M S Green; T Shohat; Y Lerman; D Cohen; R Slepon; P Duvdevani; N Varsano; R Dagan; E Mendelson
Journal:  Int J Epidemiol       Date:  1994-10       Impact factor: 7.196

View more
  3 in total

Review 1.  Serum IgG antibodies to Shigella lipopolysaccharide antigens - a correlate of protection against shigellosis.

Authors:  Dani Cohen; Shiri Meron-Sudai; Anya Bialik; Valeria Asato; Sophy Goren; Ortal Ariel-Cohen; Arava Reizis; Amit Hochberg; Shai Ashkenazi
Journal:  Hum Vaccin Immunother       Date:  2019-05-09       Impact factor: 3.452

Review 2.  Detoxified O-Specific Polysaccharide (O-SP)-Protein Conjugates: Emerging Approach in the Shigella Vaccine Development Scene.

Authors:  Dani Cohen; Shiri Meron-Sudai; Anya Bialik; Valeria Asato; Shai Ashkenazi
Journal:  Vaccines (Basel)       Date:  2022-04-24

3.  Risk factors for sporadic infection with Salmonella Infantis: a matched case-control study.

Authors:  R Bassal; A Reisfeld; I Nissan; V Agmon; D Taran; B Schemberg; D Cohen; T Shohat
Journal:  Epidemiol Infect       Date:  2013-07-23       Impact factor: 4.434

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.